BU-NOT-SET

CONTACT US
Three challenges pharma companies can overcome when choosing the right OSD partner
  • Drug product
  • Industry trends
pharma challenges
Insight
Sustainable pharmaceutical supply chains with the Science Based Targets initiative
  • Sustainability
SBTi
Insight
How CDMO partnerships can accelerate vaccine development
vaccine development
Insight
Optimising extractables and leachables testing
  • Analytical chemistry
  • Drug product
Optimising Extractables and Leachables Testing
Insight
Ready-to-use (RTU) pre-filled syringes and cartridges system
  • Drug product
  • Manufacturing
vials
Fact sheet
Recipharm’s latest investment will help meet blow-fill-seal (BFS) demand
  • Drug product
  • Manufacturing
blow fill-seal
Insight
Which biologics trends in the OSD space are set to impact drug development in 2023?
  • Drug product
  • Industry trends
Biologics trends in OSD
Insight
What are the key learnings from 2022 in pharma?
  • Drug product
  • Industry trends
Learnings 2022
Insight
Overcoming the pitfalls of pre-filled syringe filling
  • Drug product
  • Manufacturing
Pre-filled syringe pitfalls
Insight
Insight
  • Biologics
ReciBioPharm Is Advancing xRNA Production
eBook
  • Drug product
  • Manufacturing
Navigating the complexities of pre-filled syringes for biologics
Insight
  • Drug product
  • Manufacturing
Unlocking the potential of mRNA with robust lyophilisation strategies
Insight
  • Biologics
Advanced Bio Is Advancing AAV Production
Insight
  • Biologics
Advanced is advancing xRNA manufacturing
Insight
  • Drug product
  • Manufacturing
What are the innovations driving the future of sterile drug packaging?
Insight
  • Biologics
Revolutionising gene editing with end-to-end CDMO services
Insight
  • Biologics
Advanced Bio streamlines regulatory compliance
Insight
  • Biologics
Advanced Bio leads nucleic acid innovation